칼라 바이오KALA 주가

Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate

Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49) per share from the same

[SCHEDULE 13G/A] SCHEDULE 13G/A

[10-Q] 분기 실적 — 10-Q

Kala Bio announces reverse stock split

KALA BIO Inc: KALA BIO announces reverse stock split KALA BIO Inc - announces 1-for-50 reverse stock split...

Kala Bio Announces 1-For-50 Reverse Stock Split, Effective May 11

KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock") at a ratio of 1 post-split

[8-K] 중대 사건 — 8-K

[S-3] 증자 등록 — S-3

[10-K] 연 실적 — 10-K

[NT 10-K] 10-K 제출 연기 — NT 10-K

[144] 144